Redoxis is a preclinical service provider that performs tailor-made preclinical studies combining dedication, experience, and agility to provide reliable results to your project.

With core competence and experience in preclinical models for autoimmune and inflammatory conditions, Redoxis provides a wide range of in vivo and in vitro models, validated with standard reference therapies. Redoxis tailor-made high-quality services spanning across all aspects of the preclinical phase including MoA evaluation, ex vivo ranking, biomarker identification, in vivo efficacy and biomarker analyses.

By using Redoxis as your service provider you will get a dedicated and committed team with a core expertise and many years of experience in the field – for the benefit of your preclinical project!